Niosomes as a propitious carrier for topical drug delivery

Expert Opinion on Drug Delivery

Volumn 10, Issue 2, 2013, Pages 261-272

  Hamishehkar, Hamed ^a   Rahimpour, Yahya ^b   Kouhsoltani, Maryam ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carrier; Dermal drug delivery; Dermatology; Niosomes; Topical

Indexed keywords

ACECLOFENAC; BENZOYL PEROXIDE; CELECOXIB; CLOBETASOL; COAL TAR; COLECALCIFEROL DERIVATIVE; CORTICOSTEROID; DITHRANOL; ELLAGIC ACID; FINASTERIDE; FLUOROURACIL; GALLIC ACID; GALLIDERMIN; GUGGULSTERONE; HEPATITIS B VACCINE; LIDOCAINE; LIPOSOME; METHOTREXATE; MINOXIDIL; NIMESULIDE; NIOSOME; ORYZA SATIVA EXTRACT; PLACEBO; PLANT EXTRACT; RETINOIC ACID; RETINOID; RICE BRAN EXTRACT; TACROLIMUS; THAI LANNA PLANT EXTRACT; UNCLASSIFIED DRUG;

ACNE; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; HEPATITIS B; HUMAN; NONHUMAN; PSORIASIS; REVIEW; SKIN CANCER; TOPICAL DRUG ADMINISTRATION; VITILIGO;

ADMINISTRATION, TOPICAL; ANIMALS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; LIPOSOMES; PHARMACEUTICAL PREPARATIONS; SKIN; SKIN ABSORPTION;

EID: 84872706119     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.746310     Document Type: Review

References (96)

1. Akhilesh D, Hazel G, Kamath JV. Proniosomes-a propitious provesicular drug carrier. Int J Pharm Pharm Sci Res 2011;1(3):98-103
2. Brown MB, Martin GP, Jones SA, et al. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 2006;13(3):175-87
3. Rubio L, Alonso C, López O, et al. Barrier function of intact and impaired skin: percutaneous penetration of caffeine and salicylic acid. Int J Dermatol 2011;50(7):881-9
4. Dubey A, Prabhu P, Kamath J. Nano structured lipid carriers: a novel topical drug delivery system. Int J PharmTech Res 2012;4(2):705-14
5. Higaki K, Nakayama K, Suyama T, et al. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. Int J Pharm 2005;288(2):227-33 (Pubitemid 40038575)
6. Ghafourian T, Zandasrar P, Hamishekar H, et al. The effect of penetration enhancers on drug delivery through skin: a QSAR study. J Control Release 2004;99(1):113-25 (Pubitemid 39165738)
7. Sathali AAH, Rajalakshmi G. Evaluation of transdermal targeted niosomal drug delivery of terbinafine hydrochloride. Int J PharmTech Res 2010;2(3):2081-9
8. Khan A, Sharma PK, Visht S, et al. Niosomes as colloidal drug delivery system: a review. J Chronother Drug Deliv 2011;2(1):15-21
9. Handjani-Vila RM, Ribier A, Rondot B, et al. Dispersions of lamellar phases of non-ionic lipids in cosmetic products. Int J Cosmet Sci 1979;1:303-14 (Pubitemid 10125800)
10. Azeem A, Anwer MK, Talegaonkar S. Niosomes in sustained and targeted drug delivery: some recent advances. J Drug Target 2009;17(9):671-89
11. Verma AK, Bindal M. A review on niosomes: an ultimate controlled and novel drug delivery carrier. Int J Nanoparticles 2012;5(1):73-87
12. Yeh D, Pavlostathis SG. Anaerobic biodegradability of Tween surfactants used as a carbon source for the microbial reductive dechlorination of hexachlorobenzene. Water Sci Technol 2005;52(1-2):343
13. Nasr M, Mansour S, Mortada ND, et al. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul 2008;25(7):499-512
14. Jain CP, Vyas SP, Dixit VK. Niosomal system for delivery of rifampicin to lymphatics. Indian J Pharm Sci 2006;68:575-8 (Pubitemid 46087763)
15. Raja Naresh RA, Pillai GK, Udupa N, et al. Antiinflammatory activity of niosome encapsulated diclofenac sodium in arthitic rats. Indian J Pharmacol 1994;26:46-8 (Pubitemid 24120657)
16. Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 2010;99(4):2049-60
17. Malhotra M, Jain NK. Niosomes as drug carriers. Indian Drugs 1994;31(3):81-6 (Pubitemid 24176565)
18. Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 2001;228(1):43-52 (Pubitemid 32905364)
19. Abdelkader H, Wu Z, Al-Kassas R, et al. Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. Int J Pharm 2012;433(1-2):142-8
20. Lala S, Pramanick S, Mukhopadhyay S, et al. Harmine: evaluation of its antileishmanial properties in various vesicular delivery systems. J Drug Target 2004;12(3):165-75 (Pubitemid 38868164)
21. Baillie AJ, Coombs GH, Dolan TF, et al. Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. J Pharm Pharmacol 1986;38(7):502-5 (Pubitemid 16081869)
22. Desai TR, Finlay WH. Nebulization of niosomal all-trans-retinoic acid: an inexpensive alternative to conventional liposomes. Int J Pharm 2002;241(2):311-17 (Pubitemid 34718032)
23. Abd-Elbary A, El-laithy HM, Tadros MI. Sucrose stearate-based proniosomederived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm 2008;357(1-2):189-98
24. Abdelkader H, Ismail S, Hussein A, et al. Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models. Int J Pharm 2012;432(1-2):1-10
25. Pugeat M, Nicolas MH, Dechaud H, et al. Combination of cyproterone acetate and natural estrogens in the treatment of hirsutism. J Gynecol Obstet Biol Reprod (Paris) 1991;20(8):1057
26. Ruckmani K, Jayakar B, Ghosal SK. Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro release. Drug Dev Ind Pharm 2000;26(2):217-22 (Pubitemid 30111645)
27. Shi B, Fang C, You MX, et al. Influence of PEG chain length on in vitro drug release and in vivo pharmacokinetics of hydroxycamptothecin (HCPT) loaded PEG-PHDCA niosomes. Chinese Pharm J 2005;40(21):1643-6 (Pubitemid 43219674)
28. Pardakhty A, Varshosaz J, Roulholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 2007;328:130-41 (Pubitemid 44895483)
29. Firthouse PUM, Halith SM, Wahab SU, et al. Formulation and evaluation of miconazole niosomes. Int J PharmTech Res 2011;3(2):1019-22
30. Hofland HEJ, van der Geest R, Bodde HE, et al. Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro. Pharm Res 1994;11(5):659-64 (Pubitemid 24171759)
31. Hu C, Rhodes DG. Proniosomes: a novel drug carrier preparation. Int J Pharm 2000;206:110-22
32. Rahimpour Y, Hamishehkar H. Liposomes in cosmeceutics. Expert Opin Drug Deliv 2012;9(4):443-55
33. Kraemer K. Sunlight and skin cancer. Proc Natl Acad Sci USA 1997;94:11-14
34. Dahl E, Aberg M, Rausing A, et al. Basal cell carcinoma. Cancer 1992;70:104-8
35. Ananthaswamy HN, Pierceall WE. Molecular mechanism of ultraviolet radiation carcinogenesis. Photochem Photobiol 1990;52:19-136
36. Gross K, Kircik L, Kricorian G. 5% 5-Fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg 2007;33:433-40
37. Morse LG, Kendrick C, Hooper D, et al. Treatment of squamous cell carcinoma with intralesional 5-fluorouracil. Dermatol Surg 2003;29:1150-3 (Pubitemid 37370451)
38. Gupta RR, Jain SK, Varshney M. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surface B Biointerfaces 2005;41:25-32 (Pubitemid 40215481)
39. Singh BN, Singh RB, Singh J. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm 2005;298:98-107 (Pubitemid 40828331)
40. Paolino D, Cosco D, Muzzalupo R, et al. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm 2008;353(1):233-42
41. Alvi IA, Madan J, Kaushik D, et al. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis. Anticancer Drugs 2011;22(8):774-82
42. Carafa M, Santucci E, Lucania G. Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. Int J Pharm 2002;231(1):21-32 (Pubitemid 33086815)
43. Dubey V, Mishra D, Dutta T, et al. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 2007;123(2):148-54 (Pubitemid 47562141)
44. Su YH, Fang JY. Drug delivery and formulations for the topical treatment of psoriasis. Expert Opin Drug Deliv 2008;5(2):235-49
45. Puglia C, Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv 2012;9(4):429-41
46. Javadzadeh Y, Hamishehkar H. Enhancing percutaneous delivery of methotrexate using different types of surfactants. Colloids Surface B Biointerfaces 2011;82(2):422-6
47. Lakshmi PK, Devi GS, Bhaskaran S, et al. Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies. Indian J Dermatol Venereol Leprol 2007;73(3):157
48. Draelos ZD. New channels for old cosmeceuticals: aquaporin modulation. J Cosmet Dermatol 2008;7(2):83 (Pubitemid 351676524)
49. Lakshmi PK, Bhaskaran S. Phase II study of topical niosomal urea gel-an adjuvant in the treatment of psoriasis. Int J Pharm Sci Rev Res 2011;7(1):1-7
50. Choi CM, Berson DS. Cosmeceuticals. Semin Cutan Med Surg 2006;25:163-8 (Pubitemid 44572814)
51. Bissett DL, Robinson LR, Raleigh PS, et al. Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine. J Cosmet Dermatol 2007;6(1):20-6 (Pubitemid 46390325)
52. Shatalebi MA, Mostafavi SA, Moghaddas A. Niosome as a drug carrier for topical delivery of N-acetyl glucosamine. Res Pharm Sci 2010;5(2):107
53. Junyaprasert VB, Singhsa P, Suksiriworapong J, et al. Physicochemical properties and skin permeation of span 60/tween 60 niosomes of ellagic acid. Int J Pharm 2012;423(2):303-11
54. Garg BJ, Saraswat A, Bhatia A, et al. Topical treatment in vitiligo and the potential uses of new drug delivery systems. Indian J Dermatol Venereol Leprol 2010;76(3):231-8
55. Nogueira LS, Zancanaro PC, Azambuja RD. Vitiligo and emotions. An Bras Dermatol 2009;84(1):41-5
56. Kingo K, Aunin E, Karelson M, et al. Gene expression analysis of melanocortin system in vitiligo. J Dermatol Sci 2007;48(2):113-22 (Pubitemid 47380249)
57. Zhang XJ, Chen JJ, Liu JB. The genetic concept of vitiligo. J Dermatol Sci 2005;39(3):137-46
58. Manosroi J, Khositsuntiwong N, Manosroi W, et al. Enhancement of transdermal absorption, gene expression and stability of tyrosinase plasmid (pMEL34)-loaded elastic cationic niosomes: potential application in vitiligo treatment. J Pharm Sci 2010;99(8):3533-41
59. Manosroi A, Khositsuntiwong N, Gaotz F, et al. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles. J Liposome Res 2009;19(2):91-8
60. Mahor S, Rawat A, Dubey PK, et al. Cationic transfersomes based topical genetic vaccine against hepatitis B. Int J Pharm 2007;340(1-2):13-19 (Pubitemid 47043347)
61. Tang D, Shi Z, David TC. Vaccination onto bare skin. Nature 1997;388(6644):729-30
62. Shi Z, Curiel DT, Tang D. DNA-based non-invasive vaccination onto the skin. Vaccine 1999;17(17):2136-41 (Pubitemid 29197280)
63. Mishra D, Dubey V, Asthana A, et al. Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine 2006;24(22):4847-55 (Pubitemid 43776800)
64. Fan H, Lin Q, Morrissey GR, et al. Immunization via hair follicles by topical application of naked DNA to normal skin. Nat Biotechnol 1999;17:870-2 (Pubitemid 29416659)
65. Vyas SP, Singh RP, Jain S, et al. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int J Pharm 2005;296(1-2):80-6 (Pubitemid 40693375)
66. Glenn GM, Scharton-Kersten T, Vassell R, et al. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J Immunol 1998;161(7):3211-14
67. Glenn GM, Rao M, Matyas GR, et al. Skin immunization made possible by cholera toxin. Nature 1998;391(6670):851-2
68. Maheshwari C, Pandey RS, Chaurasiya A, et al. Non-ionic surfactant vesicles mediated transcutaneous immunization against hepatitis B. Int Immunopharmacol 2011;11(10):1516-22
69. Kaur K, Jain S, Sapra B, et al. Niosomal gel for site-specific sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation. Curr Drug Deliv 2007;4(4):276-82 (Pubitemid 47549496)
70. Goyal C, Ahuja M, Sharma SK. Preparation and evaluation of anti-inflammatory activity of gugulipid-loaded proniosomal gel. Acta Pol Pharm 2011;68(1):147-50
71. Shahiwala A, Misra A. Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci 2002;5(3):220
72. Lingan MA, Sathali AAH, Kumar MRV, et al. Formulation and evaluation of topical drug delivery system containing clobetasol propionate niosomes. Sci Rev Chem Commun 2011;1(1):7-17
73. Weiner N. Targeted follicular delivery of macromolecules via liposomes. Int J Pharm 1998;162(1-2):29-38 (Pubitemid 28166087)
74. Jung S, Otberg N, Thiede G, et al. Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol 2006;126(8):1728-32 (Pubitemid 44086505)
75. Ruksiriwanich W, Manosroi J, Abe M, et al. 5 [alpha]-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid. J Supercrit Fluid 2011;59:61-71
76. Manosroi A, Ruksiriwanich W, Abe M, et al. Transfollicular enhancement of gel containing cationic niosomes loaded with unsaturated fatty acids in rice (Oryza sativa) bran semi-purified fraction. Eur J Pharm Biopharm 2012;81(2):303-13
77. Manosroi J, Khositsuntiwong N, Manosroi A. Performance test of gel containing extracts from Thai Lanna medicinal plants entrapped in niosomes for hair loss treatment. J Thai Tradit Altern Med 2008;6(2):1
78. Javadzadeh Y, Shokri J, Hallaj-Nezhadi S, et al. Enhancement of percutaneous absorption of Finasteride by cosolvents, cosurfactant and surfactants. Pharm Dev Technol 2010;15(6):619-25
79. Tabbakhian M, Tavakoli N, Jaafari MR, et al. Enhancement of follicular delivery of finasteride by liposomes and niosomes: 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 2006;323(1-2):1-10 (Pubitemid 44397357)
80. Messenger A, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004;150(2):186-94 (Pubitemid 38352454)
81. Mura S, Pirot F, Manconi M, et al. Liposomes and niosomes as potential carriers for dermal delivery of minoxidil. J Drug Target 2007;15(2):101-8 (Pubitemid 46957695)
82. Balakrishnan P, Shanmugam S, Lee WS, et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 2009;377(1):1-8
83. Mali N, Darandale S, Vavia P. Niosomes as a vesicular carrier for topical administration of minoxidil: formulation and in vitro assessment. Drug Deliv Transl Res 2012;1-6. DOI: 10. 1007/s13346-012-0083-1
84. Maibach HI, Choi MJ. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol 2005;18:209-19 (Pubitemid 41159952)
85. Vyas J, Vyas P, Raval D, et al. Development of topical niosomal gel of benzoyl peroxide. ISRN Nanotechnol 2011;1-6. DOI: 10. 5402/2011/503158
86. Kempf M, Theobald U, Fiedler HP. Economic improvement of the fermentative production of gallidermin by Staphylococcus gallinarum. Biotechnol Lett 1999;21(8):663-7 (Pubitemid 29412819)
87. Manosroi A, Wongtrakul P, Manosroi J, et al. The entrapment of kojic oleate in bilayer vesicles. Int J Pharm 2005;298(1):13-25 (Pubitemid 40828325)
88. Manosroi A, Khanrin P, Lohcharoenkal W, et al. Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm 2010;392(1):304-10
89. Ridolfi DM, Marcato PD, Justo GZ, et al. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin. Colloids Surf B Biointerfaces 2012;93:36-40
90. Manconi M, Sinico C, Valenti D, et al. Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm 2006;311(1-2):11-19
91. Manconi M, Valenti D, Sinico C, et al. Niosomes as carriers for tretinoin: II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm 2003;260(2):261-72 (Pubitemid 36773923)
92. Kaur IP, Kapila M, Agrawal R. Role of novel delivery systems in developing topical antioxidants as therapeutics to combat photoageing. Ageing Res Rev 2007;6(4):271-88 (Pubitemid 350123196)
93. Rozman B, Zvonar A, Falson F, et al. Temperature-sensitive microemulsion gel: an effective topical delivery system for simultaneous delivery of vitamins C and E. AAPS PharmSciTech 2009;10(1):54-61
94. Manosroi A, Chutoprapat R, Sato Y, et al. Antioxidant activities and skin hydration effects of rice bran bioactive compounds entrapped in niosomes. J Nanosci Nanotechnol 2011;11(3):2269-77
95. Manosroi A, Chutoprapat R, Abe M, et al. Anti-aging efficacy of topical formulations containing niosomes entrapped with rice bran bioactive compounds. Pharm Biol 2012;50(2):208-24
96. Manosroi A, Jantrawut P, Akihisa T, et al. In vitro and in vivo skin anti-aging evaluation of gel containing niosomes loaded with a semi-purified fraction containing gallic acid from Terminalia chebula galls. Pharm Biol 2011;49(11):1190-203